Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cot (Q38376619)
Jump to navigation
Jump to search
scientific article published on 18 May 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cot |
scientific article published on 18 May 2017 |
Statements
1 reference
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cot (English)
1 reference
1 reference
Kamlesh Khunti
1 reference
Mikhail Kosiborod
1 reference
Matthew A Cavender
1 reference
Alex Z Fu
1 reference
Reinhard W Holl
1 reference
Kåre I Birkeland
1 reference
Niki Arya
1 reference
Johan Bodegård
1 reference
Niklas Hammar
1 reference
Peter Fenici
1 reference
CVD-REAL Investigators and Study Group*
1 reference
1 reference
Identifiers
1 reference